Clinical Trials Browser

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Carcinoma, Adenoid Cystic, Fistula, Melanoma, Carcinoma, Mucoepidermoid, Esthesioneuroblastoma, Olfactory

NCT00831623 2023-03-13

Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer

Phase NA Completed

167 enrolled 6 charts

Genitourinary

Prostatic Neoplasms

NCT02766686 2023-02-08

ProtoChoice-P

Phase NA Unknown

146 enrolled

Genitourinary

Prostatic Neoplasms

NCT05692661 2023-01-20

A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer

Phase 1 Unknown

24 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05548504 2022-09-21

HERAN2

Phase 2 Not yet recruiting

182 enrolled

Thoracic

Frailty, Carcinoma, Non-Small-Cell Lung, Radiation Injuries

NCT05212857 2022-03-16

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

Phase 2 Unknown

160 enrolled

Genitourinary

Prostatic Neoplasms

NCT05189067 2022-01-12

Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer

Phase 2/3 Unknown

190 enrolled

Breast

HER2-positive Breast Cancer

NCT05141825 2021-12-02

Proton and Carbon Ion Radiotherapy for Cervical Cancer

Phase NA Completed

16 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05106699 2021-11-04

Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases

Phase NA Recruiting

54 enrolled

Genitourinary

Prostatic Neoplasms

NCT00592501 2021-10-26

Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma

Phase 2 Completed

25 enrolled 16 charts

Head & Neck

Nasopharyngeal Carcinoma

NCT02838602 2021-09-02

ETOILE

Phase NA Recruiting

250 enrolled

Sarcoma

Carcinoma, Adenoid Cystic, Neoplasms, Sarcoma

NCT01683422 2021-08-10

Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer

Phase NA Terminated

9 enrolled 8 charts

Gastrointestinal

Pancreatic Neoplasms

NCT04717531 2021-06-04

Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer

Phase 2 Unknown

60 enrolled

Breast

Breast Neoplasms

NCT01494155 2021-02-02

Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer

Phase 2 Unknown

50 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04528394 2020-08-27

Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma

Phase 2 Unknown

136 enrolled

Head & Neck

Nasopharyngeal Carcinoma

Clinical Trials

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Radiation Medicine Patient Registry, Loma Linda University Medical Center

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer

EXTREM ION

REGI-MA-002015

PARC

A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer

Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer

PAROS

Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer

HiPPI

Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer

Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Hypofractionated Proton Beam Therapy for Localized Prostate Cancer

A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC

Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Folfox+Irinotecan+Chemort In Esophageal Cancer

Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy

Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn)

Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix

Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer

Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer

ISAC

Proton Therapy for Early Stage Breast Cancer

Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy

Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer

ProtoChoice-P

A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer

HERAN2

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer

Proton and Carbon Ion Radiotherapy for Cervical Cancer

Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases

Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma

ETOILE

Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer

Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer

Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer

Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma